Literature DB >> 16260603

Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1.

Jiliang Zhou1, Guoqing Hu, B Paul Herring.   

Abstract

Understanding the mechanism of smooth muscle cell (SMC) differentiation will provide the foundation for elucidating SMC-related diseases, such as atherosclerosis, restenosis, and asthma. In the current study, overexpression of Elk-1 in SMCs down-regulated expression of several endogenous smooth muscle-restricted proteins, including telokin, SM22alpha, and smooth muscle alpha-actin. In contrast, down-regulation of endogenous Elk-1 in smooth muscle cells increased the expression of only telokin and SM22alpha, suggesting that smooth muscle-specific promoters are differentially sensitive to the inhibitory effects of Elk-1. Consistent with this, overexpression of the DNA binding domain of Elk-1, which acts as a dominant-negative protein by displacing endogenous Elk-1, enhanced the expression of telokin and SM22alpha without affecting expression of smooth muscle alpha-actin. Elk-1 suppressed the activity of smooth muscle-restricted promoters, including the telokin promoter that does not contain a consensus Elk-1 binding site, through its ability to block myocardin-induced activation of the promoters. Gel mobility shift and chromatin immunoprecipitation assays revealed that Elk-1 binds to a nonconsensus binding site in the telokin promoter and Elk-1 binding is dependent on serum response factor (SRF) binding to a nearby CArG box. Although overexpression of the SRF-binding B-box domain of Elk-1 is sufficient to repress the myocardin activation of the telokin promoter, this repression is not as complete as that seen with an Elk-1 fragment that includes the DNA binding domain. In addition, reporter gene assays demonstrate that an intact Elk-1 binding site in the telokin promoter is required for Elk-1 to maximally inhibit promoter activity. Together, these data suggest that the differential sensitivity of smooth muscle-specific genes to inhibition by Elk-1 may play a role in the complex changes in smooth muscle-specific protein expression that are observed under pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260603      PMCID: PMC1280275          DOI: 10.1128/MCB.25.22.9874-9885.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Involvement of Elk-1 in L6E9 skeletal muscle differentiation.

Authors:  Ashwani Khurana; Chinmoy S Dey
Journal:  FEBS Lett       Date:  2002-09-11       Impact factor: 4.124

2.  Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor.

Authors:  D Wang; P S Chang; Z Wang; L Sutherland; J A Richardson; E Small; P A Krieg; E N Olson
Journal:  Cell       Date:  2001-06-29       Impact factor: 41.582

3.  Cell-specific regulatory modules control expression of genes in vascular and visceral smooth muscle tissues.

Authors:  April M Hoggatt; Gina M Simon; B Paul Herring
Journal:  Circ Res       Date:  2002-12-13       Impact factor: 17.367

4.  TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2.

Authors:  S Goetze; U Kintscher; K Kaneshiro; W P Meehan; A Collins; E Fleck; W A Hsueh; R E Law
Journal:  Atherosclerosis       Date:  2001-11       Impact factor: 5.162

5.  Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes.

Authors:  Tadashi Yoshida; Sanjay Sinha; Frédéric Dandré; Brian R Wamhoff; Mark H Hoofnagle; Brandon E Kremer; Da-Zhi Wang; Eric N Olson; Gary K Owens
Journal:  Circ Res       Date:  2003-03-27       Impact factor: 17.367

6.  Telokin expression is restricted to smooth muscle tissues during mouse development.

Authors:  B P Herring; G E Lyons; A M Hoggatt; P J Gallagher
Journal:  Am J Physiol Cell Physiol       Date:  2001-01       Impact factor: 4.249

7.  Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation.

Authors:  Kevin L Du; Hon S Ip; Jian Li; Mary Chen; Frederic Dandre; William Yu; Min Min Lu; Gary K Owens; Michael S Parmacek
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 8.  Serum response factor: toggling between disparate programs of gene expression.

Authors:  Joseph M Miano
Journal:  J Mol Cell Cardiol       Date:  2003-06       Impact factor: 5.000

Review 9.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease.

Authors:  Gary K Owens; Meena S Kumar; Brian R Wamhoff
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

10.  Myocardin: a component of a molecular switch for smooth muscle differentiation.

Authors:  Jiyuan Chen; Chad M Kitchen; Jeffrey W Streb; Joseph M Miano
Journal:  J Mol Cell Cardiol       Date:  2002-10       Impact factor: 5.000

View more
  30 in total

1.  cGMP-dependent protein kinase and the regulation of vascular smooth muscle cell gene expression: possible involvement of Elk-1 sumoylation.

Authors:  ChungSik Choi; Hassan Sellak; Felricia M Brown; Thomas M Lincoln
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-27       Impact factor: 4.733

Review 2.  Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.

Authors:  Jeffrey A Beamish; Ping He; Kandice Kottke-Marchant; Roger E Marchant
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

3.  A phospholipase Cγ1-activated pathway regulates transcription in human vascular smooth muscle cells.

Authors:  Irene Hunter; Keith S Mascall; Joe W Ramos; Graeme F Nixon
Journal:  Cardiovasc Res       Date:  2011-02-01       Impact factor: 10.787

4.  Forkhead box F2 regulation of platelet-derived growth factor and myocardin/serum response factor signaling is essential for intestinal development.

Authors:  Craig Bolte; Xiaomeng Ren; Tatiana Tomley; Vladimir Ustiyan; Arun Pradhan; April Hoggatt; Tanya V Kalin; B Paul Herring; Vladimir V Kalinichenko
Journal:  J Biol Chem       Date:  2015-01-28       Impact factor: 5.157

Review 5.  Signaling mechanisms that regulate smooth muscle cell differentiation.

Authors:  Christopher P Mack
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07       Impact factor: 8.311

6.  Repression of versican expression by microRNA-143.

Authors:  Xiaobo Wang; Guoqing Hu; Jiliang Zhou
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

7.  Elastic, silk-cardiac extracellular matrix hydrogels exhibit time-dependent stiffening that modulates cardiac fibroblast response.

Authors:  Whitney L Stoppel; Albert E Gao; Allison M Greaney; Benjamin P Partlow; Ross C Bretherton; David L Kaplan; Lauren D Black
Journal:  J Biomed Mater Res A       Date:  2016-08-11       Impact factor: 4.396

Review 8.  Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues.

Authors:  B Paul Herring; Omar El-Mounayri; Patricia J Gallagher; Feng Yin; Jiliang Zhou
Journal:  Am J Physiol Cell Physiol       Date:  2006-06-14       Impact factor: 4.249

9.  Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway.

Authors:  Kenichi Tamama; Chandan K Sen; Alan Wells
Journal:  Stem Cells Dev       Date:  2008-10       Impact factor: 3.272

10.  Downregulated protein expression of transcriptional activator ELK-1 in atrial myocardium of chronic AF patients.

Authors:  Xiangjun Zeng; Xuejun Xiao; Yueheng Wu; Huanlei Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.